microRNA-1271 impedes the development of prostate cancer by downregulating PES1 and upregulating ERβ
Related Experiment Video
Updated: Dec 20, 2025

MicroRNA Detection in Prostate Tumors by Quantitative Real-time PCR qPCR
Published on: May 16, 2012
Zhenming Jiang1, Yuxi Zhang2,3, Xi Chen4
1Department of Urology, The First Hospital of China Medical University, No. 155 Nanjing North Street, Heping District, Shenyang, 110001, Liaoning Province, People's Republic of China.
Background:
As a nucleolar protein associated with ribosome biogenesis, pescadillo homolog 1 (PES1) has been reported to participate in the development of many cancers. However, its role in prostate cancer is not clearly defined. Therefore, the aim of this study is to explore the effects and the specific mechanism of PES1 in prostate cancer.
Methods:
A microarray-based analysis was performed to analyze differentially expressed genes (DEGs) between prostate cancer and normal samples. Next, the interaction between PES1 and microRNA-1271 (miR-1271) was investigated using bioinformatics analysis in combination with dual-luciferase reporter gene assay. The expression of miR-1271 in prostate cancer cells and tissues was determined using RT-qPCR. Its effects on downstream estrogen receptor β (ERβ) signaling pathway were further examined. Moreover, we analyzed whether miR-1271 affects proliferation, apoptosis, migration and invasion of prostate cancer cells by EdU assay, flow cytometry, and Transwell assay. Lastly, a prostate cancer mouse model was conducted to measure their roles in the tumor growth.
Results:
PES1 was identified as a prostate cancer-related DEG and found to be upregulated in prostate cancer. miR-1271, which was poorly expressed in both cells and tissues of prostate cancer, can specifically bind to PES1. Additionally, overexpression of miR-1271 activated the ERβ signaling pathway. Overexpression of miR-1271 or depletion of PES1 inhibited prostate cancer cell proliferation, migration and invasion, promoted apoptosis in vitro and suppressed tumor growth in vivo.
Conclusions:
Taken together, overexpression of miR-1271 downregulates PES1 to activate the ERβ signaling pathway, leading to the delayed prostate cancer development. Our data highlights the potential of miR-1271 as a novel biomarker for the treatment of prostate cancer.
Insights
Overexpression of microRNA-1271 (miR-1271) downregulates pescadillo homolog 1 (PES1), activating the ERβ pathway and delaying prostate cancer development. miR-1271 shows potential as a novel prostate cancer treatment biomarker.
Area of Science:
- Oncology
- Molecular Biology
- Gene Regulation
Background:
- Pescadillo homolog 1 (PES1) is a nucleolar protein involved in ribosome biogenesis and implicated in various cancers.
- The specific role and mechanism of PES1 in prostate cancer progression remain unclear.
- This study investigates the function and molecular pathways of PES1 in prostate cancer.
Purpose of the Study:
- To elucidate the role of PES1 in prostate cancer.
- To identify the regulatory mechanism involving PES1 and microRNA-1271 (miR-1271) in prostate cancer.
- To explore the therapeutic potential of targeting PES1 or miR-1271 in prostate cancer.
Main Methods:
- Differential gene expression analysis identified PES1 as upregulated in prostate cancer.
- Bioinformatics and dual-luciferase assays confirmed the interaction between PES1 and miR-1271.
- RT-qPCR, cell-based assays (EdU, flow cytometry, Transwell), and a mouse model assessed the functional impact of miR-1271 and PES1.
Main Results:
- PES1 was upregulated in prostate cancer tissues and cells.
- miR-1271 was downregulated in prostate cancer and directly targets PES1.
- Overexpression of miR-1271 or PES1 depletion inhibited proliferation, migration, and invasion, while promoting apoptosis and suppressing tumor growth in vivo.
Conclusions:
- miR-1271 functions as a tumor suppressor in prostate cancer by downregulating PES1 and activating the ERβ signaling pathway.
- This miR-1271/PES1/ERβ axis offers a novel therapeutic strategy for prostate cancer.
- miR-1271 demonstrates potential as a diagnostic and therapeutic biomarker for prostate cancer.
Related Concept Videos
MicroRNAs
MicroRNAs
Abnormal Proliferation
Negative Regulator Molecules

